Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A new anti-inflammatory mechanism identified

Published on: 25/10/2022 Reading time: 1 min
image

The team "Plasticity and regeneration of myelin" co-directed by Brahim NAIT-OUMESMAR, Inserm Research Director at the Paris Brain Institute - in collaboration with Angela Giangrande's team (IGBMC, Illkirch) has just demonstrated that the Gcm2 gene has a conserved function from flies to humans in the control of inflammation of the central nervous system. This work is published in Cell Reports.

The gcm gene

The gcm (glial cells missing) gene was initially identified in the fly Drosophila melanogaster as a key regulator of the determination of undifferentiated neural cells into glial cells of the nervous system. Thus, Drosophila in which this gene is inactivated show a complete absence of glial cells and an excess of neurons. In Drosophila, gcm is also required for the differentiation of hemocytes, cells related to macrophages in mammals.

image
RNAscope detection of Gcm2 expression (red) in microglia/macrophages (Cx3cr1, green) in a spinal cord demyelinating lesion.

An anti-inflammatory effect

In this study, the researchers showed that Gcm2 is expressed by microglial cells (the resident immune cells of the central nervous system), during brain aging in a mouse model, suggesting that the increased inflammation in the aged brain is partly due to these immune cells.

The study of mice in which the Gcm2 gene is inactivated showed a modification of the morphology of microglial cells associated with a pro-inflammatory profile, during aging or in response to myelin lesions, confirming the major role of this gene in the regulation of neuroinflammation.

Very interestingly, the study showed Gcm2 protein expression in active lesions multiple sclerosis in humans, lesions in which significant inflammation is observed.

New therapeutic avenues

From a biological point of view, those results demonstrate that the expression of Gcm2 by microglial/macrophage cells favors their transition to an anti-inflammatory state which benefits to lesion repair.

Gcm is a transcription factor, i.e. a protein necessary for the initiation or regulation of gene transcription. Its expression leads to a cascade of biological reactions, known as a signaling pathway, which in turn involves several other proteins. Given the strong potential of transcription factors in coordinating the expression of several genes and the small number of known transcription factors with a similar function, the results of this work represent a major contribution to the understanding of the molecular mechanisms controlling the inflammatory response.

It also pave the way to new therapeutic targets studies for diseases where the inflammatory response must be contained, such as multiple sclerosis or other neurodegenerative diseases.

Sources

Pavlidaki A., Panic R et al. Cell Reports 41, 3, 111506, October 18, 2022
https://linkinghub.elsevier.com/retrieve/pii/S2211124722013560

Our news on the subject

À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
See all our news